Nucleus Genomics
United States · Founded 2021 · $27.5M raised
- Founded
- 2021
- Business Model
- B2C
- Website
- mynucleus.com
- Total Funding
- $27.5M
- Last Round
- $14.0M Series AJan 2025
- Rounds
- 3
About
Nucleus Genomics is a genetic optimization company helping people make better reproductive health decisions through genomics.
Summary
Nucleus Genomics is a Biotech company based in United States, founded in 2021. It has raised $27.5M in total across 3 rounds, most recently a $14.0M Series A round in Jan 2025.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...